Moreover, there was no significant difference in the expression level of PLPP4 mRNA in the patients with CDDP resistant ovarian cancer compared with the patients with CDDP-sensitive ovarian cancer (Supplemental Fig. 1A). This evidence concerns the gene PLPP4 and ovarian carcinoma.